These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 15878612

  • 21. Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists.
    Kleiman NS.
    Coron Artery Dis; 1998; 9(9):603-16. PubMed ID: 9861523
    [No Abstract] [Full Text] [Related]

  • 22. Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation.
    Frelinger AL, Furman MI, Barnard MR, Krueger LA, Dae MW, Michelson AD.
    Am J Cardiol; 2003 Nov 01; 92(9):1099-101. PubMed ID: 14583364
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes.
    Li Y, Spencer FA, Ball S, Becker RC.
    J Thromb Thrombolysis; 2000 Aug 01; 10(1):69-76. PubMed ID: 10947916
    [Abstract] [Full Text] [Related]

  • 24. Comparative analysis of various platelet glycoprotein IIb/IIIa antagonists on shear-induced platelet activation and adhesion.
    Wang X, Dorsam RT, Lauver A, Wang H, Barbera FA, Gibbs S, Varon D, Savion N, Friedman SM, Feuerstein GZ.
    J Pharmacol Exp Ther; 2002 Dec 01; 303(3):1114-20. PubMed ID: 12438534
    [Abstract] [Full Text] [Related]

  • 25. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
    Leclerc JR.
    Crit Care Med; 2002 May 01; 30(5 Suppl):S332-40. PubMed ID: 12004256
    [Abstract] [Full Text] [Related]

  • 26. Abciximab pharmacodynamics are unaffected by antecedent therapy with other GPIIb/IIIa antagonists in non-human primates.
    Nakada MT, Sassoli PM, Tam SH, Nedelman MA, Jordan RE, Kereiakes DJ.
    J Thromb Thrombolysis; 2002 Aug 01; 14(1):15-24. PubMed ID: 12652146
    [Abstract] [Full Text] [Related]

  • 27. Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.
    Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF.
    Curr Drug Metab; 2016 Aug 01; 17(2):194-203. PubMed ID: 26652157
    [Abstract] [Full Text] [Related]

  • 28. Current issues with glycoprotein IIb-IIIa antagonists.
    Schneider DJ.
    Curr Drug Targets; 2011 Nov 01; 12(12):1813-20. PubMed ID: 21718238
    [Abstract] [Full Text] [Related]

  • 29. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials.
    Bertram U, Moser M, Peter K, Kuecherer HF, Bekeredjian R, Straub A, Nordt TK, Bode C, Ruef J.
    J Thromb Thrombolysis; 2002 Dec 01; 14(3):197-203. PubMed ID: 12913399
    [Abstract] [Full Text] [Related]

  • 30. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
    Hamilton SF, Miller MW, Thompson CA, Dale GL.
    J Lab Clin Med; 2004 May 01; 143(5):320-6. PubMed ID: 15122176
    [Abstract] [Full Text] [Related]

  • 31. Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb--IIIa inhibitors than by peptide and peptidomimetic inhibitors.
    Lages B, Weiss HJ.
    Br J Haematol; 2001 Apr 01; 113(1):65-71. PubMed ID: 11328283
    [Abstract] [Full Text] [Related]

  • 32. Augmentation of inhibitory effects of glycoprotein IIb-IIIa antagonists in patients with diabetes.
    Keating FK, Whitaker DA, Sobel BE, Schneider DJ.
    Thromb Res; 2004 Apr 01; 113(1):27-34. PubMed ID: 15081562
    [Abstract] [Full Text] [Related]

  • 33. Platelet glycoprotein IIb/IIIa blockade with tirofiban: effect on aggregation caused by P256, an antibody to human IIb/IIIa receptors.
    Fisher I, Robinson P, Ritter JM.
    Br J Clin Pharmacol; 1999 Aug 01; 48(2):197-9. PubMed ID: 10417496
    [Abstract] [Full Text] [Related]

  • 34. Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
    Mousa SA, Khurana S, Forsythe MS.
    Arterioscler Thromb Vasc Biol; 2000 Apr 01; 20(4):1162-7. PubMed ID: 10764688
    [Abstract] [Full Text] [Related]

  • 35. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty.
    Verdoia M, Pergolini P, Camaro C, Restifo M, Rolla R, Schaffer A, Di Giovine G, Marino P, Bellomo G, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Blood Coagul Fibrinolysis; 2013 Jun 01; 24(4):411-8. PubMed ID: 23412353
    [Abstract] [Full Text] [Related]

  • 36. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
    Rossi F, Rossi E, Pareti FI, Colli S, Tremoli E, Gallo L.
    Haematologica; 2001 Feb 01; 86(2):192-8. PubMed ID: 11224490
    [Abstract] [Full Text] [Related]

  • 37. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.
    Tcheng JE.
    Am J Cardiol; 1999 May 06; 83(9A):7E-11E. PubMed ID: 10357575
    [No Abstract] [Full Text] [Related]

  • 38. Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists.
    Quinn M, Deering A, Stewart M, Cox D, Foley B, Fitzgerald D.
    Circulation; 1999 May 04; 99(17):2231-8. PubMed ID: 10226086
    [Abstract] [Full Text] [Related]

  • 39. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin.
    Lele M, Sajid M, Wajih N, Stouffer GA.
    Circulation; 2001 Jul 31; 104(5):582-7. PubMed ID: 11479257
    [Abstract] [Full Text] [Related]

  • 40. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S.
    Blood Coagul Fibrinolysis; 2008 Sep 31; 19(6):557-67. PubMed ID: 18685439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.